A Chinese cancer drug maker that has not been inspected by the FDA since 2018 is selling chemotherapy drugs to the U.S. due to shortages. When will the U.S. meet its critical medication needs?
The balance between scarcity and supply favors supply, even if that means importing drugs from labs the FDA has not inspected.
Meet the Chinese companies banned by Commerce and the State Department, but still able to attract billions from Wall Street fund managers.
A look at recent studies on whether companies are sourcing manufactured goods from outside of China (they are), and if any of it that manufacturing is coming home since tariffs were imposed in 2018.
House Committee hears from witnesses who call for better trade enforcement, and keeping tariffs. Meanwhile, de minimis trade rule in the crosshairs again.
Monthly trade figures show a slowing economy. Deep dives show goods gap likely to shrink. And in advanced tech, only aerospace has a trade surplus.
But rebuttal to Sullivan’s Brookings Institution speech shows a group of DC influencers are less inclined to support local manufacturing out of concerns about allied relations, more.
On Friday, March 31, the U.S. Treasury launched their latest torpedo targeting the Inflation Reduction Act’s domestic manufacturing policies. This time, it’s over what countries have a “free trade agreement” with the United States. This is actually universally understood fact: there are twenty countries. But to grow the list beyond the twenty, so as to…
Two bills circulating in the Senate want to repeal China’s Most Favored Nation trading status. CPA trade lawyer Charles Benoit explains what it means.
A look inside the Feb 28 Senate hearing on China export controls, and the Banking Committee’s debate on how to best compete with the world’s No. 2 economy.
